This suggests that the IL-6 elevation in IBD pregnancies may originate from alternative inflammatory pathways (i.e., NF-κβ, JAK/STAT3), or tissue sources (i.e., endometrium, decidua, trophoblasts in the placenta, fetal membranes). Here, STAT3 is linked to inflammatory bowel disease.